|
|
| 2.70 Delayed Data As of Feb 27 |  +0.09 / +3.45%Today’s Change | 1.26 Today|||52-Week Range 5.00 | -21.01% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $114.8M |
Clinuvel Pharmaceuticals Ltd. 190 Queen Street Melbourne Victoria (vic) 3000 |
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
| Philippe J. Wolgen | Chief Executive Officer, Director & MD |
| Darren M. Keamy | Chief Financial Officer & Secretary |
| Dennis J. Wright | Chief Scientific Officer |
| Lachlan Hay | Media Relations |
